Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine for persistent hypotension and IV vasopressor dependence after CABG
IRCT20201025049139N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypotension and Vasoplegia comparing Midodrine with Placebo (2 arms). Primary endpoints: Dependency rate to IV inotrope, ICU length of stay and 1 more. Started Oct 2020; status: completed.
02
Drugs
midodrine
03
Conditions
hypotensionVasoplegia
Beyond the preview
Go deeper on IRCT20201025049139N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201025049139N1.